
Using AI and Longitudinal Data to Transform Rare Disease Care
May 7, 2026 - 00:19:21
Radio and PodcastLive Radio & Podcasts
Whole genome sequencing is reshaping the rare disease diagnostic odyssey by replacing years of serial, narrow gene panels and helping patients with suspected rare diseases obtain faster, more definitive answers. Akash Ku...
Cutting through the Diagnostic Maze for Rare Diseases is an episode from RARECast by RARECast. Whole genome sequencing is reshaping the rare disease diagnostic odyssey by replacing years of serial, narrow gene panels and helping patients wi...
This episode belongs to RARECast.
Use the player on this page to stream the episode online.
Published Apr 30, 2026, 00:38:56 long, audio available.
Whole genome sequencing is reshaping the rare disease diagnostic odyssey by replacing years of serial, narrow gene panels and helping patients with suspected rare diseases obtain faster, more definitive answers. Akash Kumar, co‑founder and chief medical officer of MyOme, discusses where genome sequencing now fits into care pathways, how it captures hard‑to‑detect variant types; and what it means for treatment decisions, clinical trial access, and the emotional burden on families searching for a diagnosis.
You can listen to Cutting through the Diagnostic Maze for Rare Diseases online on Radio and Podcast. Open the player on this page to stream the available audio.
Cutting through the Diagnostic Maze for Rare Diseases is an episode from RARECast by RARECast.
This episode is 00:38:56 long.
This episode was published on Apr 30, 2026.
Yes. Use the heart button on the episode page to add it to your favorite episodes list.
Yes. This page shows related episodes from RARECast when more episodes are available from the podcast feed.
You can listen to Cutting through the Diagnostic Maze for Rare Diseases on this page when the episode audio is available from the podcast feed.
Cutting through the Diagnostic Maze for Rare Diseases is from RARECast by RARECast.
Published Apr 30, 2026 and 00:38:56 long